AMANDA SCHILLY: Open Payments
NPI 1467902742 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,333 in 52 payments from 17 companies in 2025. Trend: 2023 $1,543 · 2024 $1,202 · 2025 $2,333
Consulting: $1,288Food & beverage: $955Education: $90
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 1 | $1,288 |
| Evofem Biosciences, Inc. | 9 | $171 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $147 |
| Astellas Pharma US Inc | 4 | $146 |
| Sage Therapeutics, LLC | 6 | $127 |
| MILLICENT US INC | 5 | $97 |
| Sumitomo Pharma America, Inc. | 5 | $87 |
| ABBVIE INC. | 3 | $62 |
| Hologic Sales and Service, LLC | 3 | $58 |
| Exeltis, USA Inc. | 1 | $23 |
Products named: Phexxi, ZURZUVAE, FEMLYV, MYFEMBREE, Veozah, THIRD WAVE, LILETTA, LINZESS.
Industry payments across MO — which companies pay providers there.
